New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation

Por Barritt, A. Sidney, Darling, Jama M., Hayashi, Paul H.
Publicado em 2011

A blood-borne antigen induces rapid T–B cell contact: a potential mechanism for tolerance induction

Por Gütgemann, Ines, Darling, Jama M, Greenberg, Harry B, Davis, Mark M, Chien, Yueh-Hsiu
Publicado em 2002

Plasma levels of growth-related oncogene (CXCL1-3) associate with fibrosis and platelet counts in HCV-infected patients

Por Johansson, Susanne, Talloen, Willem, Tuefferd, Marianne, Darling, Jama M, Scholliers, Annick, Fanning, Gregory, Fried, Michael W, Aerssens, Jeroen
Publicado no Aliment Pharmacol Ther (2015)

Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies

Por Ku, Nam-On, Darling, Jama M., Krams, Sheri M., Esquivel, Carlos O., Keeffe, Emmet B., Sibley, Richard K., Lee, Young Moo, Wright, Teresa L., Omary, M. Bishr
Publicado em 2003

Quantitation of Pretreatment Serum IP-10 Improves the Predictive Value of an IL28B Gene Polymorphism for Hepatitis C Treatment Response

Por Darling, Jama M., Aerssens, Jeroen, Fanning, Gregory, McHutchison, John G., Goldstein, David B., Thompson, Alexander J., Shianna, Kevin V., Afdhal, Nezam H., Hudson, Michael L., Howell, Charles D., Talloen, Willem, Bollekens, Jacques, De Wit, Mieke, Scholliers, Annick, Fried, Michael W.
Publicado em 2011